SCHEMBL17463197

SCHEMBL17463197

Cc1cc(C)nc([Si](c2ccccc2)(c2ccccc2)c2ccc3c(c2)c2ccccc2n3-c2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
ATM Q13315 1/20 0.43
ALDH1A1 P00352 5/20 0.35
MEN1 O00255 3/20 0.35
TSHR P16473 3/20 0.35
KMT2A Q03164 3/20 0.35
HSD17B10 Q99714 3/20 0.35
HPGD P15428 3/20 0.35
MAPK1 P28482 2/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HTT P42858 2/20 0.34
PTGER4 P35408 1/20 0.34
RXFP1 Q9HBX9 2/20 0.32
LMNA P02545 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HKDC1 Q2TB90 1/20 0.32
POLB P06746 1/20 0.32
BRCA1 P38398 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17463201 0.84 KDM4E (0.46) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL17463269 0.83 KDM4E (0.51) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL17461139 0.83 KDM4E (0.51) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL19044681 0.82 L3MBTL1 (0.60) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL22665491 0.82 L3MBTL1 (0.60) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL17463239 0.81 KDM4E (0.49) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL17461039 0.81 L3MBTL1 (0.49) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL25634986 0.81 KDM4E (0.47) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL18381748 0.80 L3MBTL1 (0.58) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL17463232 0.80 L3MBTL1 (0.58) KDM4EL3MBTL1ATMALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160028030-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD., (KR) 2016-01-28 US disclosed
US-20160028030-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD., (KR) 2016-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160028030-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CCNE1 KDM4E 1882/4885L3MBTL1 863/4885ATM 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.